EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
149 hedge funds and large institutions have $1.31B invested in Eagle Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
149
Holding in Top 10
6
Calls
$20.7M
Puts
$18.4M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$9.24M | |
| 3 | +$7.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.3M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.62M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$29M | |
| 3 | -$21.3M | |
| 4 |
Morgan Stanley
New York
|
-$9.54M |
| 5 |
JCI
Jet Capital Investors
New York
|
-$9.44M |